81 FR 65363 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 184 (September 22, 2016)

Page Range		65363-65364
FR Document		2016-22815
Federal Register, Volume 81 Issue 184 (Thursday, September 22, 2016)
[Federal Register Volume 81, Number 184 (Thursday, September 22, 2016)]
[Notices]
[Pages 65363-65364]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-22815]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cancer Immunopathology and Immunotherapy.
    Date: October 6, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Syed M. Quadri, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 
20892, 301-435-1211, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Auditory Processes.
    Date: October 11-12, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: John Bishop, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, [email protected].

    Name of Committee: Vascular and Hematology Integrated Review 
Group: Hemostasis and Thrombosis Study Section.
    Date: October 20, 2016.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review 
Officer, Vascular and Hematology IRG, Center for Scientific Review, 
National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC 
7802, Bethesda, MD 20892, (301) 806-7314, [email protected].

    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group: Language and Communication Study Section.
    Date: October 20-21, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037.
    Contact Person: Wind Cowles, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3172, Bethesda, MD 20892, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel: Ocular Surface, Cornea, and Refractive Error.
    Date: October 20, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 2620 Hotel, 2620 Jones Street, San Francisco, CA 
94133.
    Contact Person: Kristin Kramer, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD 
20892, (301) 437-0911, [email protected].

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Drug Discovery and Mechanisms of 
Antimicrobial Resistance Study Section.
    Date: October 20-21, 2016.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 
20036.
    Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, [email protected].

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Virology--A Study Section.
    Date: October 20-21, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Alexandria, 1900 Diagonal Road, 
Alexandria, VA 22314.
    Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD 
20892, 301-496-6980, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurobiology of Epilepsy, Spinal Cord 
Injury, and Protein, Processing in Neurodegeneration.
    Date: October 20, 2016.
    Time: 8:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892-7846, 301-
435-1236, [email protected].

    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group; Child Psychopathology and Developmental 
Disabilities Study Section.
    Date: October 20-21, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The William F. Bolger Center, 9600 Newbridge Drive, 
Potomac, MD 20854.
    Contact Person: Jane A. Doussard-Roosevelt, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD 
20892, (301) 435-4445, [email protected].

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Pathogenic Eukaryotes Study Section.
    Date: October 20-21, 2016.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Washington DC Downtown, 1199 Vermont Avenue 
NW., Washington, DC 20005.
    Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 
20892, 301-435-2306, [email protected].


[[Page 65364]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Drug Discovery and Mechanisms of Antimicrobial Resistance.
    Date: October 20, 2016.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 
20036.
    Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Language and Communication.
    Date: October 20, 2016.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Palomar Hotel, 2121 P Street NW., Washington, DC 20037.
    Contact Person: Maribeth Champoux, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3182, MSC 7759, Bethesda, MD 
20892, 301-594-3163, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 16, 2016.
Anna Snouffer,
 Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-22815 Filed 9-21-16; 8:45 am]
 BILLING CODE 4140-01-P
Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices 65363

NINDS/NIH/DHHS, Neuroscience Center, Scientific Review, National Institutes of Time: 8:00 a.m. to 1:00 p.m.
6001 Executive Blvd., Suite 3204, MSC 9529, Health, 6701 Rockledge Drive, Room 6210, Agenda: To review and evaluate grant
Bethesda, MD 20892–9529, 301–496–0660, MSC 7804, Bethesda, MD 20892, 301–435– applications.
webbere@mail.nih.gov. 1211, quadris@csr.nih.gov. Place: St. Gregory Hotel, 2033 M Street
Name of Committee: National Institute of This notice is being published less than 15 NW., Washington, DC 20036.
Neurological Disorder and Stroke Initial days prior to the meeting due to the timing Contact Person: Guangyong Ji, Ph.D.,
Review Group; Neurological Sciences and limitations imposed by the review and Scientific Review Officer, Center for
Disorders B. funding cycle. Scientific Review, National Institutes of
Date: October 27–28, 2016. Name of Committee: Center for Scientific Health, 6701 Rockledge Drive, Room 3188,
Time: 8:00 a.m. to 3:00 p.m. Review Special Emphasis Panel; Member MSC 7808, Bethesda, MD 20892, 301–435–
Agenda: To review and evaluate grant Conflict: Auditory Processes. 1146, jig@csr.nih.gov.
applications. Date: October 11–12, 2016. Name of Committee: Infectious Diseases
Place: Lorien Hotel and Spa, 1600 King Time: 8:00 a.m. to 6:00 p.m. and Microbiology Integrated Review Group;
Street, Alexandria, VA 22314. Agenda: To review and evaluate grant Virology—A Study Section.
Contact Person: Birgit Neuhuber, Ph.D., applications. Date: October 20–21, 2016.
Scientific Review Officer, Scientific Review Place: National Institutes of Health, 6701 Time: 8:00 a.m. to 5:00 p.m.
Branch, Division of Extramural Research, Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant
NINDS/NIH/DHHS, Neuroscience Center, (Virtual Meeting). applications.
6001 Executive Blvd., Suite 3204, MSC 9529, Contact Person: John Bishop, Ph.D., Place: Embassy Suites Alexandria, 1900
Bethesda, MD 20892–9529, 301–496–0288, Scientific Review Officer, Center for Diagonal Road, Alexandria, VA 22314.
neuhuber@ninds.nih.gov. Scientific Review, National Institutes of Contact Person: Kenneth M. Izumi, Ph.D.,
(Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 5182, Scientific Review Officer, Center for
Program Nos. 93.853, Clinical Research MSC 7844, Bethesda, MD 20892, (301) 408– Scientific Review, National Institutes of
Related to Neurological Disorders; 93.854, 9664, bishopj@csr.nih.gov. Health, 6701 Rockledge Drive, Room 3204,
Biological Basis Research in the MSC 7808, Bethesda, MD 20892, 301–496–
Name of Committee: Vascular and
Neurosciences, National Institutes of Health, 6980, izumikm@csr.nih.gov.
Hematology Integrated Review Group:
HHS) Hemostasis and Thrombosis Study Section. Name of Committee: Center for Scientific
Dated: September 16, 2016. Date: October 20, 2016. Review Special Emphasis Panel; Member
Time: 8:00 a.m. to 7:00 p.m. Conflict: Neurobiology of Epilepsy, Spinal
Sylvia L. Neal, Cord Injury, and Protein, Processing in
Agenda: To review and evaluate grant
Program Analyst, Office of Federal Advisory applications. Neurodegeneration.
Committee Policy. Place: Residence Inn Bethesda, 7335 Date: October 20, 2016.
[FR Doc. 2016–22814 Filed 9–21–16; 8:45 am] Wisconsin Avenue, Bethesda, MD 20814. Time: 8:00 a.m. to 6:30 p.m.
BILLING CODE 4140–01–P Contact Person: Bukhtiar H. Shah, DVM, Agenda: To review and evaluate grant
Ph.D., Scientific Review Officer, Vascular applications.
and Hematology IRG, Center for Scientific Place: National Institutes of Health, 6701
Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892
DEPARTMENT OF HEALTH AND
Rockledge Drive, Room 4120, MSC 7802, (Virtual Meeting).
HUMAN SERVICES Contact Person: Wei-Qin Zhao, Ph.D.,
Bethesda, MD 20892, (301) 806–7314,
shahb@csr.nih.gov. Scientific Review Officer, Center for
National Institutes of Health Scientific Review, National Institutes of
Name of Committee: Biobehavioral and Health, 6701 Rockledge Drive, Room 5181,
Center for Scientific Review; Notice of Behavioral Processes Integrated Review MSC 7846, Bethesda, MD 20892–7846, 301–
Closed Meetings Group: Language and Communication Study 435–1236, zhaow@csr.nih.gov.
Section.
Pursuant to section 10(d) of the Date: October 20–21, 2016. Name of Committee: Biobehavioral and
Federal Advisory Committee Act, as Behavioral Processes Integrated Review
Time: 8:00 a.m. to 5:00 p.m.
amended (5 U.S.C. App.), notice is Group; Child Psychopathology and
Agenda: To review and evaluate grant
Developmental Disabilities Study Section.
hereby given of the following meetings. applications.
Date: October 20–21, 2016.
The meetings will be closed to the Place: Hotel Palomar, 2121 P Street NW.,
Time: 8:00 a.m. to 5:00 p.m.
public in accordance with the Washington, DC 20037.
Agenda: To review and evaluate grant
provisions set forth in sections Contact Person: Wind Cowles, Ph.D.,
applications.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Center for
Place: The William F. Bolger Center, 9600
Scientific Review, National Institutes of
as amended. The grant applications and Newbridge Drive, Potomac, MD 20854.
Health, 6701 Rockledge Drive, Room 3172, Contact Person: Jane A. Doussard-
the discussions could disclose Bethesda, MD 20892, cowleshw@csr.nih.gov.
confidential trade secrets or commercial Roosevelt, Ph.D., Scientific Review Officer,
Name of Committee: Center for Scientific Center for Scientific Review, National
property such as patentable material, Review Special Emphasis Panel: Ocular Institutes of Health, 6701 Rockledge Drive,
and personal information concerning Surface, Cornea, and Refractive Error. Room 3184, MSC 7848, Bethesda, MD 20892,
individuals associated with the grant Date: October 20, 2016. (301) 435–4445, doussarj@csr.nih.gov.
applications, the disclosure of which Time: 8:00 a.m. to 5:00 p.m. Name of Committee: Infectious Diseases
would constitute a clearly unwarranted Agenda: To review and evaluate grant and Microbiology Integrated Review Group;
invasion of personal privacy. applications. Pathogenic Eukaryotes Study Section.
Place: Pier 2620 Hotel, 2620 Jones Street, Date: October 20–21, 2016.
Name of Committee: Center for Scientific
San Francisco, CA 94133. Time: 8:30 a.m. to 5:00 p.m.
Review Special Emphasis Panel; Member
Contact Person: Kristin Kramer, Ph.D., Agenda: To review and evaluate grant
Conflict: Cancer Immunopathology and
Scientific Review Officer, Center for applications.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Immunotherapy.
Date: October 6, 2016. Scientific Review, National Institutes of Place: Residence Inn Washington DC
Time: 12:00 p.m. to 2:00 p.m. Health, 6701 Rockledge Drive, Room 5205, Downtown, 1199 Vermont Avenue NW.,
Agenda: To review and evaluate grant MSC 7846, Bethesda, MD 20892, (301) 437– Washington, DC 20005.
applications. 0911, kramerkm@csr.nih.gov. Contact Person: Tera Bounds, DVM, Ph.D.,
Place: National Institutes of Health, 6701 Name of Committee: Infectious Diseases Scientific Review Officer, Center for
Rockledge Drive, Bethesda, MD 20892 and Microbiology Integrated Review Group; Scientific Review, National Institutes of
(Telephone Conference Call). Drug Discovery and Mechanisms of Health, 6701 Rockledge Drive, Room 3198,
Contact Person: Syed M. Quadri, Ph.D., Antimicrobial Resistance Study Section. MSC 7808, Bethesda, MD 20892, 301–435–
Scientific Review Officer, Center for Date: October 20–21, 2016. 2306, boundst@csr.nih.gov.

VerDate Sep<11>2014 18:58 Sep 21, 2016 Jkt 238001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\22SEN1.SGM 22SEN1
65364 Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices

Name of Committee: Center for Scientific Name of Committee: Board of Scientific practice the inventions embodied in the
Review Special Emphasis Panel; Drug Advisors. U.S. Patents and Patent Applications
Discovery and Mechanisms of Antimicrobial Open: October 31, 2016, 1:00 p.m. to 4:00 listed in the Summary Information
Resistance. p.m. section of this notice to Aspyrian
Date: October 20, 2016. Agenda: RFA and RFP Concept Reviews.
Time: 1:00 p.m. to 2:00 p.m. Place: National Cancer Institute Shady
Therapeutics, Inc. (‘‘Aspyrian’’) located
Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room in San Diego, California USA.
applications. TE406, Rockville, MD 20850 (Virtual DATES: Only written comments and/or
Place: St. Gregory Hotel, 2033 M Street Meeting). applications for a license which are
NW., Washington, DC 20036. Contact Person: Paulette S. Gray, Ph.D., received by the National Cancer
Contact Person: John C. Pugh, Ph.D., Executive Secretary, Division of Extramural Institute’s Technology Transfer Center
Scientific Review Officer, Center for Activities, National Cancer Institute—Shady on or before October 7, 2016 will be
Scientific Review, National Institutes of Grove, National Institutes of Health, 9609
considered.
Health, 6701 Rockledge Drive, Room 1206, Medical Center Drive, Room 7W444,
MSC 7808, Bethesda, MD 20892, (301) 435– Bethesda, MD 20892, 240–276–6340, grayp@ ADDRESSES: Requests for copies of the
2398, pughjohn@csr.nih.gov. mail.nih.gov. patent application, inquiries, and
Name of Committee: Center for Scientific Any interested person may file written comments relating to the contemplated
Review Special Emphasis Panel; Language comments with the committee by forwarding exclusive license should be directed to:
and Communication. the statement to the Contact Person listed on Thomas Clouse, J.D., Senior Licensing
Date: October 20, 2016. this notice. The statement should include the and Patenting Manager, NCI Technology
Time: 1:00 p.m. to 2:00 p.m. name, address, telephone number and when Transfer Center, 9609 Medical Center
Agenda: To review and evaluate grant applicable, the business or professional
applications. affiliation of the interested person.
Drive, RM 1E530 MSC 9702, Bethesda,
Place: Palomar Hotel, 2121 P Street NW., In the interest of security, NCI Shady Grove MD 20892–9702 (for business mail),
Washington, DC 20037. has instituted stringent procedures for Rockville, MD 20850–9702 Telephone:
Contact Person: Maribeth Champoux, entrance into the NCI Shady Grove building. (240)–276–5530; Facsimile: (240)–276–
Ph.D., Scientific Review Officer, Center for Visitors will be asked to show one form of 5504 Email: thomas.clouse@nih.gov.
Scientific Review, National Institutes of identification (for example, a government- SUPPLEMENTARY INFORMATION:
Health, 6701 Rockledge Drive, Room 3182, issued photo ID, driver’s license, or passport)
MSC 7759, Bethesda, MD 20892, 301–594– and to state the purpose of their visit. Intellectual Property
3163, champoum@csr.nih.gov. Information is also available on the United States Provisional Patent
(Catalogue of Federal Domestic Assistance Institute’s/Center’s home page: http://
Application No. 62/202,252, filed
Program Nos. 93.306, Comparative Medicine; deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional August 7, 2015 ‘‘Near Infrared
93.333, Clinical Research, 93.306, 93.333,
information for the meeting will be posted PhotoImmunoTherapy (NIR–PIT) of
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National when available. Suppressor Cells to Treat Cancer’’ [HHS
Institutes of Health, HHS) (Catalogue of Federal Domestic Assistance Reference No. E–231–2015/0–US–01];
Program Nos. 93.392, Cancer Construction; and
Dated: September 16, 2016. PCT Patent Application PCT/US2016/
93.393, Cancer Cause and Prevention
Anna Snouffer, Research; 93.394, Cancer Detection and 045090, filed August 2, 2016 ‘‘Near
Deputy Director, Office of Federal Advisory Diagnosis Research; 93.395, Cancer Infrared PhotoImmunoTherapy (NIR–
Committee Policy. Treatment Research; 93.396, Cancer Biology PIT) of Suppressor Cells to Treat
[FR Doc. 2016–22815 Filed 9–21–16; 8:45 am] Research; 93.397, Cancer Centers Support; Cancer’’ [HHS Reference No. E–231–
BILLING CODE 4140–01–P 93.398, Cancer Research Manpower; 93.399, 2015/0–PCT–02].
Cancer Control, National Institutes of Health,
The patent rights in these inventions
HHS)
have been assigned and/or exclusively
DEPARTMENT OF HEALTH AND Dated: September 16, 2016. licensed to the government of the
HUMAN SERVICES Melanie J. Gray, United States of America.
Program Analyst, Office of Federal Advisory The prospective exclusive license
National Institutes of Health Committee Policy. territory may be worldwide and the
[FR Doc. 2016–22817 Filed 9–21–16; 8:45 am] field of use may be limited to the use
National Cancer Institute; Notice of
BILLING CODE 4140–01–P of Licensed Patent Rights for the
Meeting
following: ‘‘Use of photosensitizing
Pursuant to section 10(a) of the antibody-fluorophore conjugate defined
Federal Advisory Committee Act, as DEPARTMENT OF HEALTH AND by the Licensed Patent Rights by itself
amended (5 U.S.C. App.), notice is HUMAN SERVICES for PhotoImmunoTherapy (PIT), or in
hereby given of a meeting of the combination with cancer therapeutic
National Cancer Institute Board of National Institutes of Health agents, to treat cancer or hyperplasia.’’
Scientific Advisors. This technology discloses the concept
The meeting will be open to the Prospective Grant of Exclusive Patent of binding an anti-foxp3+ antibody to
public as indicated below, with License: Development of an Antibody- IR700 to bind to foxp3+ T-cells. When
attendance limited to space available. Drug Conjugate for Use in irradiated with near infrared light
Individuals who plan to attend and PhotoImmunoTherapy localized at the site of the solid tumor,
need special assistance, such as sign controlled local knockdown of foxp3+
asabaliauskas on DSK3SPTVN1PROD with NOTICES

AGENCY: National Institutes of Health,
language interpretation or other HHS. negative regulatory T-cells in tumors
reasonable accommodations, should ACTION: Notice. results in rapid tumor death without the
notify the Contact Person listed below severe autoimmune response that is
in advance of the meeting. The meeting SUMMARY: The National Cancer Institute, induced by systemic knock-down of
will also be videocast and can be an institute of the National Institutes of foxp3+ T-cells. Theoretically, this
accessed from the NIH Videocasting and Health, Department of Health and technology can be used in a broad
Podcasting Web site (http:// Human Services, is contemplating the spectrum of patients with a variety of
videocast.nih.gov). grant of an exclusive patent license to solid cancers including those with

VerDate Sep<11>2014 18:58 Sep 21, 2016 Jkt 238001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\22SEN1.SGM 22SEN1
Document Created: 2016-09-22 01:03:41
Document Modified: 2016-09-22 01:03:41
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 6, 2016.
FR Citation		81 FR 65363
81 FR 65363 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 184 (September 22, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
